- €16.10m
- €11.68m
- €16.18m
- 59
- 43
- 13
- 29
Annual balance sheet for Biotika as, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 5.03 | 5.57 | 2.8 | 2.6 | 3.57 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2.09 | 1.54 | 1.26 | 0.89 | 1.51 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 12.4 | 10.8 | 9.93 | 9 | 11.1 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 15.4 | 14.9 | 14.2 | 13.7 | 13.1 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 34.3 | 31.4 | 30.5 | 28.3 | 30.4 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.62 | 2.18 | 2.8 | 2.05 | 3.48 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 5.98 | 3.3 | 3.72 | 2.9 | 4.14 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | 28.3 | 28.1 | 26.8 | 25.4 | 26.3 |
| Total Liabilities & Shareholders' Equity | 34.3 | 31.4 | 30.5 | 28.3 | 30.4 |
| Total Common Shares Outstanding |